Anders Tullgren currently serves as Chairperson of the Board at BerGenBio ASA and holds the position of Strategic Advisor at DRI Capital, as well as Healthcare Sector Advisor at Goldman Sachs. Additionally, Anders is an Industrial Partner at ZAAL Management and has been involved with Xbrane Biopharma AB as Chairperson of the Board of Directors since 2018. Since 2017, Anders has participated on the Board of Directors for Branding Science and founded Tullgren Consulting Ltd, focusing on strategy, transformation, and growth. As Executive Advisor at Szpirt & Company and Chairman of the Board of Directors at Farmalisto, Anders collaborates on strategic planning and governance in the healthcare sector, particularly in Latin America. Previously, Anders contributed to Dizlin Pharmaceuticals AB as a Board member in developing new strategies for innovative treatments in Parkinson's disease. Anders holds advanced management and board director qualifications from INSEAD and a Master of Science in Pharmaceutical Sciences from Uppsala University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices